First, is the equity fundraising by listed for-profit medical institutions in line with the healthcare industry’s policy direction?
As the Chinese healthcare authority looks into the impact of listed for-profit medical institutions on the development of healthcare in the country, investors are concerned that the interest in the sector may spark another crackdown, similar to that of the Chinese education sector.
According to the National Health Commission of China, it will be assessing the situation from three aspects, says DBS Group Research analyst Rachel Tan.
